Mario Pérez-Diego Selected Research

Anaphylaxis (Anaphylactic Shock)

1/2022	Cannabinoid WIN55212-2 impairs peanut-allergic sensitization and promotes the generation of allergen-specific regulatory T cells.
1/2022	Cannabinoids induce functional Tregs by promoting tolerogenic DCs via autophagy and metabolic reprograming.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Mario Pérez-Diego Research Topics

Disease

2	Anaphylaxis (Anaphylactic Shock) 01/2022 - 01/2022
1	Inflammation (Inflammations) 01/2023
1	COVID-19 01/2022
1	Sepsis (Septicemia) 01/2022
1	Peanut Hypersensitivity (Peanut Allergy) 01/2022
1	Atopic Dermatitis (Atopic Eczema) 01/2020
1	Hypersensitivity (Allergy) 01/2020
1	Asthma (Bronchial Asthma) 01/2020

Drug/Important Bio-Agent (IBA)

4	CannabinoidsIBA 01/2023 - 01/2020
1	(3R)- ((2,3- dihydro- 5- methyl- 3- ((4- morpholinyl)methyl)pyrrolo- (1,2,3- de)- 1,4- benzoxazin- 6- yl)(1- naphthalenyl))methanone (WIN 55,212)IBA 01/2022
1	AllergensIBA 01/2022
1	Interleukin-10 (Interleukin 10)IBA 01/2022